Combined Immunodeficiency
Gene: CIITA
13 individuals of 11 unrelated families; two mouse models
Homozygous and compound heterozygous variants were identified in these individuals (missense, nonsense and splicing) resulting in premature stop codon and truncated protein, or inactive protein.
Affected individuals typically present with sever (recurrent) respiratory and gastrointestinal tract infections and defective MHC II expression in PBMCs.Created: 22 Jul 2021, 5:03 a.m. | Last Modified: 22 Jul 2021, 5:03 a.m.
Panel Version: 0.216
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Bare Lymphocyte Syndrome, type II, complementation group A MIM# 209920; varied ID; bronchiolitis; pneumonia; severe autoimmune cytopaenia; CD4 T-cell lymphopaenia; hypogammaglobulinemia; absence of antigen-induced immune response; chronic diarrhoea; recurrent respiratory infections; recurrent gastroenteritis; failure to thrive; liver/biliary tract disease
Publications
Gene: ciita has been classified as Green List (High Evidence).
Phenotypes for gene: CIITA were changed from to Bare Lymphocyte Syndrome, type II, complementation group A MIM# 209920; varied ID; bronchiolitis; pneumonia; severe autoimmune cytopaenia; CD4 T-cell lymphopaenia; hypogammaglobulinemia; absence of antigen-induced immune response; chronic diarrhoea; recurrent respiratory infections; recurrent gastroenteritis; failure to thrive; liver/biliary tract disease
Publications for gene: CIITA were set to
Mode of inheritance for gene: CIITA was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: CIITA was added gene: CIITA was added to Combined immunodeficiency_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: CIITA was set to Unknown